A complicated role for the renin–angiotensin system during pregnancy: highlighting the importance of drug discovery
Authors:
- Marie DarbyMDMarie Darby
- James N MartinJMJames N Martin
- 2 August 2013
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 12 (6) , 857-864
Abstract
Introduction: Blood pressure management is recommended to avoid maternal cerebrovascular or cardiovascular compromise during pregnancy. Current antihypertensive treatment during pregnancy with positive safety profiles includes labetalol, hydralazine, methyldopa and nifedipine. Areas covered: Many earlier animal and human studies indicate that angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) are associated with fetopathy; therefore, these drugs are contraindicated during pregnancy, especially if these medications were taken during the second and third trimesters. The role of the RAS is quite complex, with fetal development heavily dependent on its appropriate expression and function. New findings indicate that the placental unit expresses its own RAS in order to regulate angiogenesis. Multiple studies have shown that women with abnormal uterine doppler sonography produce an agonistic autoantibody to the angiotensin I receptor, implicating a role for RAS function and regulation in abnormal pregnancies. Importantly, interruption of a normal RAS compromises fetal development. Expert opinion: Traditional medications that inhibit components of RAS for long-term hypertension control are not appropriate for use before or during pregnancy. Further study and drug discovery are needed to find alternative pathways for treatment of hypertensive disorders when pregnancy is present or a possibility.Keywords
This publication has 52 references indexed in Scilit:
- Agonistic Autoantibodies to the Angiotensin II Type I Receptor Cause Pathophysiologic Characteristics of PreeclampsiaGender Medicine, 2012
- The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor BlockersObstetrics and Gynecology International, 2011
- Angiotensin II Type 1 Autoantibody Induced Hypertension During Pregnancy Is Associated With Renal Endothelial DysfunctionGender Medicine, 2011
- Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsiaCurrent Opinion in Pharmacology, 2011
- Renin Angiotensin Signaling in Normal Pregnancy and PreeclampsiaSeminars in Nephrology, 2011
- Angiogenic Factors and PreeclampsiaSeminars in Nephrology, 2011
- Increased Sensitivity to Angiotensin II Is Present Postpartum in Women With a History of Hypertensive PregnancyHypertension, 2010
- The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsiaJournal of Experimental Medicine, 2009
- Development of fetal brain renin–angiotensin system and hypertension programmed in fetal originsProgress in Neurobiology, 2009
- Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant miceNature Medicine, 2008